This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:

fact-checked

proofread

Advancing causal inference in clinical neuroscience research

Advancing causal inference in clinical neuroscience research
Visual illustrations of the basic concepts in causal inference. Visual illustrations of the basic concepts in causal inference. (A) ITE. Since the individual cannot simultaneously receive and not receive the treatment, we are unable to observe the difference between the POs (icon with boundary) of receiving treatment and not receiving treatment for the same individual, i.e. ITE is unobservable; (B) ATE and ATT. ATE is the average treatment effect for the whole group while ATT is the average treatment effect for the treated group, ATE = ATT for the ideal RCT (being in the control or treatment group is random and unrelated to the outcome), but they are not necessarily the same in the observational studies. We use the observed outcome to estimate ATE and ATT. Credit: TranSpread

In a perspective published in Psychoradiology, researchers from Shanghai Jiao Tong University confronted causal inference in clinical neuroscience research and advocate for more clarity and transparency in causal analyses. The review distinguishes between traditional statistical analysis and causal inference, highlighting the need for specific causal assumptions, like the Stable Unit Treatment Value Assumption (SUTVA).

Randomized controlled trials (RCTs) are considered the gold standard for estimating causal effects. The authors stress the importance of imitating RCTs in through quasi-experimental techniques, given the constraints on RCT data availability due to . In observational studies, researchers grapple with controlling intervention assignments and justifying causal assumptions. Breaches of these assumptions could cause imbalanced covariates between treatment and control groups, needing to create balance and replicate RCT results.

The definition of intervention in clinical neuroscience extends beyond medication administration to include brain stimulation or targeted surgery, demanding a multivariate mechanistic approach for causal inference. The authors advise researchers to provide detailed information about their causal formulation of research questions, including study type, causal effects, and observed outcomes. They emphasize the necessity of justifying causal assumptions and performing sensitivity analysis to evaluate results' robustness.

This review highlights the challenges and opportunities in advancing causal inference in clinical neuroscience research. By adopting clear and transparent practices in conducting and reporting causal analyses, researchers can improve the rigor and interpretability of their findings. This interdisciplinary effort will contribute to a better understanding of causal relationships in clinical neuroscience and facilitate evidence-based decision-making in the field.

More information: Qing Wang et al, Claim causality with clarity, Psychoradiology (2023). DOI: 10.1093/psyrad/kkad007

Provided by TranSpread
Citation: Advancing causal inference in clinical neuroscience research (2023, July 13) retrieved 19 April 2024 from https://medicalxpress.com/news/2023-07-advancing-causal-inference-clinical-neuroscience.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Statistical tools for valid causal inference with fewer assumptions

 shares

Feedback to editors